SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000905718-16-001634
Filing Date
2016-08-18
Accepted
2016-08-17 18:39:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G onconova_13gjul292016.htm SC 13G 34985
  Complete submission text file 0000905718-16-001634.txt   36653
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Subject) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87566 | Film No.: 161839678
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022
Business Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022 212-446-2473
TYNDALL CAPITAL PARTNERS L P (Filed by) CIK: 0001219314 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G